SG11201404757WA - Pyrazolopyrimidinyl inhibitors of ubiquitin-activating enzyme - Google Patents

Pyrazolopyrimidinyl inhibitors of ubiquitin-activating enzyme

Info

Publication number
SG11201404757WA
SG11201404757WA SG11201404757WA SG11201404757WA SG11201404757WA SG 11201404757W A SG11201404757W A SG 11201404757WA SG 11201404757W A SG11201404757W A SG 11201404757WA SG 11201404757W A SG11201404757W A SG 11201404757WA SG 11201404757W A SG11201404757W A SG 11201404757WA
Authority
SG
Singapore
Prior art keywords
ubiquitin
activating enzyme
pyrazolopyrimidinyl
inhibitors
pyrazolopyrimidinyl inhibitors
Prior art date
Application number
SG11201404757WA
Other languages
English (en)
Inventor
Roushan Afroze
Indu T Bharathan
Jeffrey P Ciavarri
Paul E Fleming
Jeffrey L Gaulin
Mario Girard
Steven P Langston
Francois R Soucy
Tzu-Tshin Wong
Yingchun Ye
Original Assignee
Millennium Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Millennium Pharm Inc filed Critical Millennium Pharm Inc
Publication of SG11201404757WA publication Critical patent/SG11201404757WA/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SG11201404757WA 2012-02-17 2013-02-14 Pyrazolopyrimidinyl inhibitors of ubiquitin-activating enzyme SG11201404757WA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261600070P 2012-02-17 2012-02-17
PCT/US2013/026113 WO2013123169A1 (en) 2012-02-17 2013-02-14 Pyrazolopyrimidinyl inhibitors of ubiquitin-activating enzyme

Publications (1)

Publication Number Publication Date
SG11201404757WA true SG11201404757WA (en) 2014-09-26

Family

ID=48982730

Family Applications (2)

Application Number Title Priority Date Filing Date
SG11201404757WA SG11201404757WA (en) 2012-02-17 2013-02-14 Pyrazolopyrimidinyl inhibitors of ubiquitin-activating enzyme
SG10201606581RA SG10201606581RA (en) 2012-02-17 2013-02-14 Pyrazolopyrimidinyl inhibitors of ubiquitin-activating enzyme

Family Applications After (1)

Application Number Title Priority Date Filing Date
SG10201606581RA SG10201606581RA (en) 2012-02-17 2013-02-14 Pyrazolopyrimidinyl inhibitors of ubiquitin-activating enzyme

Country Status (30)

Country Link
US (4) US9290500B2 (enrdf_load_stackoverflow)
EP (3) EP3173413B1 (enrdf_load_stackoverflow)
JP (1) JP6122877B2 (enrdf_load_stackoverflow)
KR (1) KR20140123104A (enrdf_load_stackoverflow)
CN (1) CN104136399B (enrdf_load_stackoverflow)
AR (1) AR092797A1 (enrdf_load_stackoverflow)
BR (1) BR112014020365B1 (enrdf_load_stackoverflow)
CA (1) CA2864672C (enrdf_load_stackoverflow)
CL (1) CL2014002181A1 (enrdf_load_stackoverflow)
CO (1) CO7071135A2 (enrdf_load_stackoverflow)
CR (1) CR20140380A (enrdf_load_stackoverflow)
DO (1) DOP2014000187A (enrdf_load_stackoverflow)
EA (1) EA035020B1 (enrdf_load_stackoverflow)
EC (1) ECSP14019113A (enrdf_load_stackoverflow)
ES (1) ES2739150T3 (enrdf_load_stackoverflow)
GE (1) GEP201706687B (enrdf_load_stackoverflow)
HK (1) HK1201817A1 (enrdf_load_stackoverflow)
IL (1) IL234016A0 (enrdf_load_stackoverflow)
MA (1) MA35932B1 (enrdf_load_stackoverflow)
MX (1) MX352963B (enrdf_load_stackoverflow)
NZ (1) NZ628969A (enrdf_load_stackoverflow)
PE (1) PE20142244A1 (enrdf_load_stackoverflow)
PH (1) PH12014501832A1 (enrdf_load_stackoverflow)
SG (2) SG11201404757WA (enrdf_load_stackoverflow)
TN (1) TN2014000351A1 (enrdf_load_stackoverflow)
TW (1) TWI593688B (enrdf_load_stackoverflow)
UA (1) UA116534C2 (enrdf_load_stackoverflow)
UY (1) UY34629A (enrdf_load_stackoverflow)
WO (1) WO2013123169A1 (enrdf_load_stackoverflow)
ZA (1) ZA201406103B (enrdf_load_stackoverflow)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8008307B2 (en) 2006-08-08 2011-08-30 Millennium Pharmaceuticals, Inc. Heteroaryl compounds useful as inhibitors of E1 activating enzymes
SG11201404757WA (en) 2012-02-17 2014-09-26 Millennium Pharm Inc Pyrazolopyrimidinyl inhibitors of ubiquitin-activating enzyme
CA2880813A1 (en) 2012-08-03 2014-02-06 Millennium Pharmaceuticals, Inc. Indole-substituted pyrrolopyrimidinyl inhibitors of uba6
WO2015002994A2 (en) 2013-07-02 2015-01-08 Millennium Pharmaceuticals, Inc. Heteroaryl compounds useful as inhibitors of sumo activating enzyme
DK3164130T3 (da) 2014-07-01 2019-10-28 Millennium Pharm Inc Heteroaryle forbindelser anvendelige som inhibatorer af sumo-aktiverende enzym
EP3212650B1 (en) 2014-10-29 2021-02-17 Millennium Pharmaceuticals, Inc. Administration of ubiquitin-activating enzyme inhibitor and chemotherapeutic agents
TW201628621A (zh) 2014-10-29 2016-08-16 千禧製藥公司 泛素活化酶抑制劑及輻射之施用
MA54092A (fr) 2018-10-30 2021-09-08 Kronos Bio Inc Composés, compositions et procédés de modulation de l'activité de cdk9
WO2023021498A1 (en) * 2021-08-16 2023-02-23 Moya Bio Ltd. Fused azole and furan based nucleoside analogs and uses thereof

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1485396A2 (en) 2002-02-28 2004-12-15 Biota, Inc. Nucleoside 5'-monophosphate mimics and their prodrugs
NZ539162A (en) 2002-09-04 2006-07-28 Schering Corp Pyrazolopyrimidines as cyclin dependent kinase inhibitors
US7196092B2 (en) 2002-09-04 2007-03-27 Schering Corporation N-heteroaryl pyrazolopyrimidines as cyclin dependent kinase inhibitors
US7563798B2 (en) 2002-09-04 2009-07-21 Schering Corporation Substituted pyrazolo[1,5-a]pyrimidines as protein kinase inhibitors
CN1701073B (zh) 2002-09-04 2011-06-22 先灵公司 作为细胞周期蛋白依赖激酶抑制剂的吡唑并[1,5-a]嘧啶
EP1608652A1 (en) 2003-03-31 2005-12-28 Vernalis (Cambridge) Limited Pyrazolopyrimidine compounds and their use in medicine
JP2005008581A (ja) * 2003-06-20 2005-01-13 Kissei Pharmaceut Co Ltd 新規なピラゾロ[1,5−a]ピリミジン誘導体、それを含有する医薬組成物およびそれらの用途
WO2005037845A1 (en) 2003-10-17 2005-04-28 Rigel Pharmaceuticals, Inc. Benzothiazole and thiazole[5,5-b] pyridine compositions and their use as ubiquitin ligase inhibitors
JP2008503591A (ja) 2004-06-22 2008-02-07 ライジェル ファーマシューティカルズ, インコーポレイテッド ユビキチンリガーゼ阻害剤
SI1848718T1 (sl) 2005-02-04 2012-12-31 Millennium Pharmaceuticals, Inc. Inhibitorji E1 aktivacijskih enzimov
US7642266B2 (en) 2005-10-06 2010-01-05 Schering Corporation Substituted pyrazolo[1,5-a]pyrimidines as protein kinase inhibitors
EA031335B1 (ru) * 2006-02-02 2018-12-28 Миллениум Фармасьютикалз, Инк. Производные пирролопиримидинов
CN101395698B (zh) * 2006-02-28 2010-06-09 兰姆研究股份公司 用于液体处理盘形物体的装置及方法
US8008307B2 (en) 2006-08-08 2011-08-30 Millennium Pharmaceuticals, Inc. Heteroaryl compounds useful as inhibitors of E1 activating enzymes
KR101555258B1 (ko) * 2006-08-08 2015-09-24 밀레니엄 파머슈티컬스 인코퍼레이티드 E1 활성화 효소의 억제제로서 유용한 헤테로아릴 화합물
CA2691987C (en) 2007-06-12 2016-08-16 Achaogen, Inc. Antibacterial agents
JP5479336B2 (ja) 2007-08-02 2014-04-23 ミレニアム ファーマシューティカルズ, インコーポレイテッド E1活性化酵素阻害剤の合成のためのプロセス
US9216983B2 (en) 2007-12-21 2015-12-22 Board Of Regents, University Of Texas System Dihydroorotate dehydrogenase inhibitors with selective anti-malarial activity
US9334242B2 (en) 2008-06-16 2016-05-10 Gtx, Inc. Compounds for treatment of cancer
WO2010086040A1 (en) 2009-01-29 2010-08-05 Biomarin Iga, Ltd. Pyrazolo-pyrimidines for treatment of duchenne muscular dystrophy
WO2010088518A2 (en) 2009-01-31 2010-08-05 Kalypsys, Inc. Heterocyclic modulators of gpr119 for treatment of disease
NZ621128A (en) * 2009-05-14 2015-08-28 Millennium Pharm Inc Hydrochloride salt of ((1s,2s,4r)-4-{ 4-[(1s)-2,3-dihydro-1h-inden-1-ylamino]-7h-pyrrolo[2,3-d]pyrimidin-7-yl} -2-hydroxycyclopentyl)methyl sulfamate
US20120077814A1 (en) 2010-09-10 2012-03-29 Zhong Wang Sulfonamide, sulfamate, and sulfamothioate derivatives
EP3323414A1 (en) 2011-08-24 2018-05-23 Millennium Pharmaceuticals, Inc. Inhibitors of nedd8-activating enzyme
SG11201404757WA (en) 2012-02-17 2014-09-26 Millennium Pharm Inc Pyrazolopyrimidinyl inhibitors of ubiquitin-activating enzyme
CA2880813A1 (en) 2012-08-03 2014-02-06 Millennium Pharmaceuticals, Inc. Indole-substituted pyrrolopyrimidinyl inhibitors of uba6
WO2015002994A2 (en) 2013-07-02 2015-01-08 Millennium Pharmaceuticals, Inc. Heteroaryl compounds useful as inhibitors of sumo activating enzyme
DK3164130T3 (da) 2014-07-01 2019-10-28 Millennium Pharm Inc Heteroaryle forbindelser anvendelige som inhibatorer af sumo-aktiverende enzym

Also Published As

Publication number Publication date
US9796725B2 (en) 2017-10-24
AR092797A1 (es) 2015-05-06
MX352963B (es) 2017-12-15
US20170369499A1 (en) 2017-12-28
EP2814791A1 (en) 2014-12-24
DOP2014000187A (es) 2014-10-15
CO7071135A2 (es) 2014-09-30
ZA201406103B (en) 2017-11-29
BR112014020365A2 (pt) 2020-12-22
TWI593688B (zh) 2017-08-01
PE20142244A1 (es) 2015-01-07
EA035020B1 (ru) 2020-04-17
CN104136399B (zh) 2018-08-07
ES2739150T3 (es) 2020-01-29
CL2014002181A1 (es) 2014-12-12
GEP201706687B (en) 2017-06-26
EA201400831A1 (ru) 2014-12-30
NZ628969A (en) 2017-03-31
WO2013123169A1 (en) 2013-08-22
UA116534C2 (uk) 2018-04-10
US20170217968A1 (en) 2017-08-03
TW201345909A (zh) 2013-11-16
EP3173413B1 (en) 2019-05-01
MA35932B1 (fr) 2014-12-01
TN2014000351A1 (en) 2015-12-21
BR112014020365B1 (pt) 2023-02-23
EP3536692B1 (en) 2021-04-07
US20160244455A1 (en) 2016-08-25
CN104136399A (zh) 2014-11-05
JP6122877B2 (ja) 2017-04-26
EP3536692A1 (en) 2019-09-11
EP2814791A4 (en) 2015-08-19
JP2015508775A (ja) 2015-03-23
US9663525B2 (en) 2017-05-30
US9290500B2 (en) 2016-03-22
ECSP14019113A (es) 2015-09-30
MX2014009944A (es) 2014-11-10
SG10201606581RA (en) 2016-09-29
CA2864672A1 (en) 2013-08-22
UY34629A (es) 2013-09-02
CA2864672C (en) 2018-01-09
PH12014501832A1 (en) 2014-11-17
EP3173413A1 (en) 2017-05-31
KR20140123104A (ko) 2014-10-21
CR20140380A (es) 2014-10-28
US10202389B2 (en) 2019-02-12
US20130217682A1 (en) 2013-08-22
IL234016A0 (en) 2014-09-30
HK1201817A1 (en) 2015-09-11
US20140088096A9 (en) 2014-03-27

Similar Documents

Publication Publication Date Title
IL259958B (en) Heterocyclic glutaminase inhibitors
IL232358A0 (en) Inhibitors of phosphodiesterase type 10a
AP4029A (en) Inhibitors of beta-secretase
ZA201500953B (en) Fused pyrimidines as inhibitors of p97 complex
HUE045663T2 (hu) Pteridinek, mint FGFR inhibitorok
ZA201406103B (en) Pyrazolopyrimidinyl inhibitors of ubiquitin-activating enzyme
SG11201400102WA (en) Inhibitors of nedd8-activating enzyme
IL236963A0 (en) beta-secretase inhibitors
RS57082B1 (sr) Piridazinoni kao inhibitori daao enzima
IL237626A0 (en) Novel inhibitory compounds of type a10 phosphodiesterase
PL2888228T3 (pl) Inhibitory oddziaływania CD40-TRAF6
IL238739A0 (en) Novel phosphodiesterase type 10a inhibitory compounds
GB201312311D0 (en) Uses of enzyme inhibitors
AP2014007697A0 (en) Quinoline derivatives as PDE1OA enzyme inhibitors
GB201223308D0 (en) Enzyme inhibitors
HK1191650A (en) Picolinamide inhibitors of kinases
AU2012905067A0 (en) IMPROVED INHIBITORS OF Grb7